Back to insights

Cosmo Films, AstraZeneca, Lazard, Amur Capital Management Corporation, Mednow

📩 New Slides - 23 August 2024

Hello PitchDeckGuy readers!

Here are the top 5 decks we found on PitchSend today.

1. Cosmo Films

Cosmo Films is a leading player in the BOPP films industry with a robust export presence, operating since 1981.

This slide deck highlights:

  • Now leading in thermal lamination films.

  • Manufacturing in India, Korea, USA with 288K MT capacity.

  • Net sales from ₹1,403 to ₹2,157 crores.

  • Independent board.

  • Committed to sustainability.

2. AstraZeneca

AstraZeneca's 2023 revenue increased by 4%, reflecting strong commercial performance.

This slide deck highlights:

  • Core EPS +21% to $4.07.

  • Oncology revenue +22% to $8.8B.

  • BioPharmaceuticals +10% to $5.2B.

  • Rare Disease +12% to $3.8B.

  • Emerging Markets +13%, with China +9%.

3. Lazard

Lazard is a global financial firm with $228 billion in assets, excelling in advisory and investment.

This slide deck highlights:

  • Operates in 26 countries with 3,400 staff.

  • 175 years in asset management and advisory.

  • 62% of AUM in non-USD

  • Switching to U.S. C-Corp in 2024 for tax.

  • Focused on profitability and cost control.

Reading this and not subscribed?

4. Amur Capital Management Corporation

Amur Capital Management Corporation manages nearly $1B in assets and provides residential mortgage investment options.

This slide deck highlights:

  • 50+ years in Canadian mortgage lending.

  • Blue Stripe offers 14.44% returns.

  • Manchester Investments targets 7.0% yield.

  • Ryan Mortgage aims for 9.5% yield.

  • Manages 7,000+ mortgages.

5. Mednow

Mednow is a leader in the $47 Billion Canadian pharmacy market.

This slide deck highlights:

  • 18% CAGR for ePharmacy from 2021 to 2028.

  • 96% of Canadians trust pharmacists.

  • 49% are open to virtual pharmacies.

  • 50% of users are 45-65 years old.

  • 250K lives in talks for Mednow for Business.

See you tomorrow,

What do you think?

Give us feedback!

Login or Subscribe to participate in polls.

Reading this and not subscribed?